Home › Funds › Integral Health Asset Management, LLC › NVS
Integral Health Asset Management, LLC position in NVS
NOVARTIS AG · Health Care
Integral Health Asset Management, LLC reported holding 100,000 shares of NVS (NOVARTIS AG) in its Q3 2026 13F filing — a position valued at US$14.3M, representing 0.92% of its reported portfolio and ranking #35 among its reported holdings. Integral Health Asset Management, LLC has disclosed NVS holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Integral Health Asset Management, LLC's NVS position evolved
Integral Health Asset Management, LLC first disclosed a stake in NVS in Q3 2023 at 200,000 shares (US$20.4M). The position peaked in Q1 2026 at 250,000 shares, worth US$38.2M. Across 12 filings, Integral Health Asset Management, LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 100,000 shares valued at US$14.3M — a reduction of -100,000 shares quarter over quarter.. Notable position changes include a 33% increase in Q2 2024 (shares rose 8% over the following quarter), a 33% trim in Q3 2024 (shares fell 17% over the following quarter), a 50% trim in Q3 2026 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 200.00K | $20.37M | New |
| Q4 2023 | 225.00K | $22.72M | Add |
| Q1 2024 | 225.00K | $21.76M | Hold |
| Q2 2024 | 300.00K | $31.94M | Add |
| Q3 2024 | 200.00K | $23.00M | Reduce |
| Q1 2025 | 250.00K | $27.87M | New |
| Q2 2025 | 200.00K | $24.20M | Reduce |
| Q3 2025 | 200.00K | $25.65M | Hold |
| Q4 2025 | 250.00K | $34.47M | Add |
| Q1 2026 | 250.00K | $38.19M | Hold |
| Q2 2026 | 200.00K | $31.34M | Reduce |
| Q3 2026 | 100.00K | $14.26M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVS and 13F data
NVS (NOVARTIS AG) is a Health Care company. 20 other funds we track also report a position in NVS — the largest reported positions include Fisher Asset Management, LLC (US$2.39B), PRIMECAP MANAGEMENT CO/CA/ (US$938.9M), LOOMIS SAYLES & CO L P (US$689.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVS
- Fisher Asset Management, LLC 16.76M sh · $2.39B · Q3 2026
- PRIMECAP MANAGEMENT CO/CA/ 6.59M sh · $938.89M · Q3 2026
- LOOMIS SAYLES & CO L P 4.83M sh · $689.20M · Q3 2026
- Cullen Capital Management, LLC 1.95M sh · $278.55M · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 1.72M sh · $250.18M · Q3 2026
More on Integral Health Asset Management, LLC
FAQ
How long has Integral Health Asset Management, LLC held NVS?
Integral Health Asset Management, LLC has disclosed NVS holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
What is Integral Health Asset Management, LLC's current position in NVS?
As of Q3 2026, Integral Health Asset Management, LLC holds 100.00K shares of NVS (NOVARTIS AG), valued at $14.26M, representing 0.92% of its reported portfolio and ranking #35.
Has Integral Health Asset Management, LLC been buying or selling NVS?
In the latest 13F filing (Q3 2026), Integral Health Asset Management, LLC reduced its position in NVS. The position peaked in Q1 2026 at 250.00K shares.
Which other funds hold NVS?
Other major institutional holders of NVS include Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.